Is Soliris® for Me?

Soliris is the first and only approved medication for the treatment of patients with PNH to reduce hemolysis. Soliris improves the symptoms and reduces the major health problems associated with PNH.1

How does PNH affect you?

You probably have a million questions. What is PNH? How and why did I get it? How can I manage it? Click on the resources below to get more information.


Soliris Toolkit

Use these interactive tools and resources to improve your understanding of PNH treatment.

PNH Symptom Checkup Chart
Track your symptoms and lab results—including your LDH levels. This tool was designed to help you and your doctor keep your PNH in check. Bring it with you to every visit.

Lab Tracker
Track your lab results over time, and see your progress. Just bring this tool with you to your doctor’s visits, and record your lab dates and results.

Patient/Doctor Discussion Guide
Want to get to the heart of PNH? Our guide can help you ask the right questions.





IMPORTANT SAFETY INFORMATION

WARNING: SERIOUS MENINGOCOCCAL INFECTIONS

Soliris increases the risk of meningococcal infections. Meningococcal infection may become rapidly life-threatening or fatal if not recognized and treated early

  • Vaccinate patients with a meningococcal vaccine at least 2 weeks prior to receiving the first dose of Soliris; revaccinate according to current medical guidelines for vaccine use
  • Monitor patients for early signs of meningococcal infections, evaluate immediately if infection is suspected, and treat with antibiotics if necessary

The effect of anticoagulant withdrawal during Soliris treatment has not been studied. Therefore, treatment with Soliris should not alter anticoagulant management.

Soliris is generally well tolerated. The most frequent adverse events observed in clinical studies were headache, a runny nose (nasopharyngitis), back pain, nausea, and tiredness (fatigue).

Please see full prescribing information for SOLIRIS, including boxed WARNING regarding serious meningitis.


Reference: 1. Soliris® [package insert]. Cheshire, CT: Alexion Pharmaceuticals Inc; 2009.